News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,278 Results
Type
Article (1944)
Company Profile (17)
Press Release (68317)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (26210)
Career Advice (58)
Deals (3899)
Drug Delivery (1)
Drug Development (5563)
Employer Resources (3)
FDA (1116)
Job Trends (1146)
News (35673)
Policy (2097)
Tag
2027 Pharm Country Standard (1)
Academia (106)
Accelerated approval (7)
Allergies (21)
Alliances (2692)
ALS (38)
Alzheimer's disease (209)
Antibody-drug conjugate (ADC) (109)
Approvals (1298)
Artificial intelligence (193)
Autoimmune disease (57)
Automation (21)
Bankruptcy (8)
Best Places to Work (1281)
Biosimilars (53)
Biotechnology (9)
Bladder cancer (91)
Brain cancer (9)
Breast cancer (251)
Cancer (1646)
Cardiovascular disease (104)
Career advice (46)
Career pathing (1)
CAR-T (61)
CDC (1)
Cell therapy (186)
Cervical cancer (18)
Clinical research (6577)
Collaboration (617)
Compensation (404)
Complete response letters (4)
COVID-19 (188)
CRISPR (33)
C-suite (253)
Cystic fibrosis (36)
Data (1888)
Depression (21)
Diabetes (75)
Diagnostics (867)
Digital health (12)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (76)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (61)
Earnings (24826)
Editorial (1)
Employer resources (3)
Events (7674)
Executive appointments (364)
FDA (2182)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (495)
Gene editing (65)
Generative AI (8)
Gene therapy (139)
GLP-1 (157)
Government (202)
Grass and pollen (3)
Guidances (261)
Healthcare (1744)
HIV (35)
Huntington's disease (8)
IgA nephropathy (26)
Immunology and inflammation (33)
Immuno-oncology (15)
Indications (38)
Infectious disease (265)
Inflammatory bowel disease (32)
Inflation Reduction Act (2)
Influenza (27)
Intellectual property (55)
Interviews (8)
IPO (2858)
IRA (1)
Job creations (109)
Job search strategy (44)
JPM (2)
Kidney cancer (6)
Labor market (8)
Layoffs (20)
Legal (491)
Liver cancer (23)
Longevity (3)
Lung cancer (246)
Lymphoma (126)
Machine learning (16)
Manufacturing (191)
MASH (28)
Medical device (1538)
Medtech (1554)
Mergers & acquisitions (1392)
Metabolic disorders (190)
mRNA (3)
Multiple sclerosis (34)
NASH (1)
Neurodegenerative disease (84)
Neuropsychiatric disorders (17)
Neuroscience (508)
NextGen: Class of 2026 (388)
Non-profit (162)
Now hiring (2)
Obesity (73)
Opinion (4)
Ovarian cancer (50)
Pain (36)
Pancreatic cancer (57)
Parkinson's disease (76)
Partnered (2)
Patents (96)
Patient recruitment (149)
Peanut (8)
People (2916)
Pharmaceutical (5)
Pharmacy benefit managers (3)
Phase 1 (1791)
Phase 2 (2517)
Phase 3 (2644)
Pipeline (2281)
Policy (7)
Postmarket research (253)
Preclinical (690)
Press Release (1)
Prostate cancer (90)
Psychedelics (1)
Radiopharmaceuticals (42)
Rare diseases (202)
Real estate (301)
Recruiting (2)
Regulatory (2334)
Reports (11)
Research institute (141)
Resumes & cover letters (8)
Rett syndrome (19)
RNA editing (2)
RSV (26)
Schizophrenia (29)
Series A (73)
Series B (72)
Service/supplier (1)
Sickle cell disease (22)
Special edition (3)
Spinal muscular atrophy (9)
Sponsored (1)
Startups (175)
Stomach cancer (1)
Supply chain (32)
Tariffs (1)
The Weekly (1)
Vaccines (143)
Venture capital (13)
Weight loss (37)
Women's health (33)
Date
Last 7 days (309)
Last 30 days (871)
Last 365 days (9914)
2026 (1530)
2025 (10161)
2024 (5989)
2023 (4066)
2022 (6436)
2021 (5008)
2020 (4849)
2019 (3484)
2018 (2752)
2017 (2354)
2016 (1550)
2015 (2200)
2014 (1480)
2013 (1066)
2012 (1178)
2011 (1386)
2010 (1306)
Location
Africa (48)
Alabama (8)
Alaska (1)
Arizona (22)
Arkansas (4)
Asia (3864)
Australia (532)
California (4056)
Canada (712)
China (238)
Colorado (161)
Connecticut (174)
Delaware (208)
Europe (9063)
Florida (387)
Georgia (83)
Hawaii (3)
Idaho (6)
Illinois (341)
India (18)
Indiana (107)
Iowa (7)
Japan (209)
Kansas (15)
Kentucky (7)
Louisiana (10)
Maine (17)
Maryland (327)
Massachusetts (2946)
Michigan (81)
Minnesota (182)
Missouri (45)
Montana (6)
Nebraska (4)
Nevada (48)
New Hampshire (19)
New Jersey (1016)
New Mexico (4)
New York (882)
North Carolina (370)
North Dakota (2)
Northern California (1984)
Ohio (109)
Oklahoma (4)
Oregon (7)
Pennsylvania (508)
Puerto Rico (5)
Rhode Island (9)
South America (69)
South Carolina (7)
Southern California (1500)
Tennessee (57)
Texas (604)
United States (12984)
Utah (79)
Virginia (102)
Washington D.C. (15)
Washington State (301)
West Virginia (2)
Wisconsin (93)
70,278 Results for "99".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VitriVax Awarded $9.9M Grant to Enable Scaling up of Clinical Manufacturing
October 15, 2025
·
2 min read
Press Releases
Mitochondrial DNA Market to Reach USD 687.99 Million by 2034
July 31, 2025
·
1 min read
Press Releases
eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity
July 30, 2025
·
6 min read
Series B
Nuclidium Nets $99M Series B for Copper-Based Radiopharma Platform
Nuclidium’s radiopharmaceutical platform is unique in its use of copper-based payloads, which the biotech claims can deliver higher doses while also being safer.
July 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity
June 10, 2025
·
2 min read
BioCapital
KeViRx, Inc. Awarded $1.99 Million
KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced the receipt of $1.99 million in grant funding from the U.S. Department of Defense’s Peer Reviewed Medical Research Program.
June 11, 2024
·
3 min read
Press Releases
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
October 1, 2025
·
6 min read
Press Releases
Elicio Therapeutics Reports ELI-002 7P Achieved Robust mKRAS-Specific T Cell Responses in 99% of Evaluable Patients in Ongoing Phase 2 AMPLIFY-7P Trial
September 18, 2025
·
11 min read
Press Releases
Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation
September 18, 2025
·
15 min read
Press Releases
Biosimilars Market Size Estimated to Reach USD 175.99 Billion by 2034
February 26, 2025
·
1 min read
1 of 7,028
Next
